Pfizer Korea to launch an anti-cancer drug, Sutent.

Pfizer Korea celebrated the market launching of Sutent (sunitinib maleate), a multiple targeted anti-cancer drug, in attendance of the top company executives and other 100 staffs at Grand hotel Hongjaedong, on March 9 for the objectives of shedding their vision with anti-cancer drug business.

In the event Dr. Dugan delivered a presentation and other lecturers presented informations and stra...